FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138207816> ?p ?o ?g. }

• W2138207816 endingPage "330" @default.
• W2138207816 startingPage "323" @default.
• W2138207816 abstract "BackgroundWe aimed to accurately estimate the frequency of a hexanucleotide repeat expansion in C9orf72 that has been associated with a large proportion of cases of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).MethodsWe screened 4448 patients diagnosed with ALS (El Escorial criteria) and 1425 patients with FTD (Lund-Manchester criteria) from 17 regions worldwide for the GGGGCC hexanucleotide expansion using a repeat-primed PCR assay. We assessed familial disease status on the basis of self-reported family history of similar neurodegenerative diseases at the time of sample collection. We compared haplotype data for 262 patients carrying the expansion with the known Finnish founder risk haplotype across the chromosomal locus. We calculated age-related penetrance using the Kaplan-Meier method with data for 603 individuals with the expansion.FindingsIn patients with sporadic ALS, we identified the repeat expansion in 236 (7·0%) of 3377 white individuals from the USA, Europe, and Australia, two (4·1%) of 49 black individuals from the USA, and six (8·3%) of 72 Hispanic individuals from the USA. The mutation was present in 217 (39·3%) of 552 white individuals with familial ALS from Europe and the USA. 59 (6·0%) of 981 white Europeans with sporadic FTD had the mutation, as did 99 (24·8%) of 400 white Europeans with familial FTD. Data for other ethnic groups were sparse, but we identified one Asian patient with familial ALS (from 20 assessed) and two with familial FTD (from three assessed) who carried the mutation. The mutation was not carried by the three Native Americans or 360 patients from Asia or the Pacific Islands with sporadic ALS who were tested, or by 41 Asian patients with sporadic FTD. All patients with the repeat expansion had (partly or fully) the founder haplotype, suggesting a one-off expansion occurring about 1500 years ago. The pathogenic expansion was non-penetrant in individuals younger than 35 years, 50% penetrant by 58 years, and almost fully penetrant by 80 years.InterpretationA common Mendelian genetic lesion in C9orf72 is implicated in many cases of sporadic and familial ALS and FTD. Testing for this pathogenic expansion should be considered in the management and genetic counselling of patients with these fatal neurodegenerative diseases.FundingFull funding sources listed at end of paper (see Acknowledgments)." @default.
• W2138207816 created "2016-06-24" @default.
• W2138207816 creator A5000927105 @default.
• W2138207816 creator A5001310894 @default.
• W2138207816 creator A5005343323 @default.
• W2138207816 creator A5006096323 @default.
• W2138207816 creator A5006706373 @default.
• W2138207816 creator A5007363301 @default.
• W2138207816 creator A5009553687 @default.
• W2138207816 creator A5010017708 @default.
• W2138207816 creator A5010857043 @default.
• W2138207816 creator A5015982152 @default.
• W2138207816 creator A5018020880 @default.
• W2138207816 creator A5020514779 @default.
• W2138207816 creator A5021394368 @default.
• W2138207816 creator A5022524234 @default.
• W2138207816 creator A5022587380 @default.
• W2138207816 creator A5027489586 @default.
• W2138207816 creator A5028342652 @default.
• W2138207816 creator A5035072440 @default.
• W2138207816 creator A5038782753 @default.
• W2138207816 creator A5041309484 @default.
• W2138207816 creator A5042566383 @default.
• W2138207816 creator A5048648105 @default.
• W2138207816 creator A5049549975 @default.
• W2138207816 creator A5053419046 @default.
• W2138207816 creator A5054069514 @default.
• W2138207816 creator A5054635855 @default.
• W2138207816 creator A5055313700 @default.
• W2138207816 creator A5056047751 @default.
• W2138207816 creator A5056125632 @default.
• W2138207816 creator A5056137794 @default.
• W2138207816 creator A5056969742 @default.
• W2138207816 creator A5057989264 @default.
• W2138207816 creator A5062092102 @default.
• W2138207816 creator A5063767082 @default.
• W2138207816 creator A5064998679 @default.
• W2138207816 creator A5065321812 @default.
• W2138207816 creator A5065438352 @default.
• W2138207816 creator A5067439253 @default.
• W2138207816 creator A5071831090 @default.
• W2138207816 creator A5072408761 @default.
• W2138207816 creator A5073438832 @default.
• W2138207816 creator A5073614894 @default.
• W2138207816 creator A5077048801 @default.
• W2138207816 creator A5078142848 @default.
• W2138207816 creator A5079371866 @default.
• W2138207816 creator A5080478575 @default.
• W2138207816 creator A5081540348 @default.
• W2138207816 creator A5082436384 @default.
• W2138207816 creator A5083470216 @default.
• W2138207816 creator A5083680637 @default.
• W2138207816 creator A5084072142 @default.
• W2138207816 creator A5084783422 @default.
• W2138207816 creator A5085975040 @default.
• W2138207816 creator A5086167465 @default.
• W2138207816 creator A5086206120 @default.
• W2138207816 creator A5087727224 @default.
• W2138207816 creator A5089453718 @default.
• W2138207816 creator A5090628289 @default.
• W2138207816 creator A5091305213 @default.
• W2138207816 date "2012-04-01" @default.
• W2138207816 modified "2023-10-18" @default.
• W2138207816 title "Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study" @default.
• W2138207816 cites W1963943740 @default.
• W2138207816 cites W1964177214 @default.
• W2138207816 cites W1971565607 @default.
• W2138207816 cites W1974032274 @default.
• W2138207816 cites W1975262530 @default.
• W2138207816 cites W2001432662 @default.
• W2138207816 cites W2003618511 @default.
• W2138207816 cites W2019894444 @default.
• W2138207816 cites W2076313803 @default.
• W2138207816 cites W2076404202 @default.
• W2138207816 cites W2078207720 @default.
• W2138207816 cites W2080105198 @default.
• W2138207816 cites W2080802641 @default.
• W2138207816 cites W2090477471 @default.
• W2138207816 cites W2100623206 @default.
• W2138207816 cites W2101738226 @default.
• W2138207816 cites W2104103676 @default.
• W2138207816 cites W2109641307 @default.
• W2138207816 cites W2137404280 @default.
• W2138207816 cites W2150523249 @default.
• W2138207816 cites W2154945114 @default.
• W2138207816 cites W2162622841 @default.
• W2138207816 cites W2163955717 @default.
• W2138207816 doi "https://doi.org/10.1016/s1474-4422(12)70043-1" @default.
• W2138207816 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3322422" @default.
• W2138207816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22406228" @default.
• W2138207816 hasPublicationYear "2012" @default.
• W2138207816 type Work @default.
• W2138207816 sameAs 2138207816 @default.
• W2138207816 citedByCount "975" @default.
• W2138207816 countsByYear W21382078162012 @default.
• W2138207816 countsByYear W21382078162013 @default.
• W2138207816 countsByYear W21382078162014 @default.
• W2138207816 countsByYear W21382078162015 @default.

• next